GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma
By United One News · AI-generated summary of 2 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
The Telangana GST appellate authority confirmed a ₹4.6 crore demand to reverse excess input tax credit claimed by Aurobindo Pharma for FY 2020‑21.
- The order was issued by the Appellate Joint Commissioner (ST) of the Malkajgiri Division, Hyderabad.
- Aurobindo Pharma’s stock fell 1.4% following the adverse ruling.
- The case involves the Central GST Act and Telangana GST Act for the 2020‑21 financial year.
Covered by 2 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma
Timeline
First reported by The Hindu BusinessLine on ; 2 articles from 2 outlets so far.
Who is covering this story
- Center (2): The Hindu BusinessLine, Free Press Journal